Ingevity Quarterly Cash Flow Statement
NYSE: NGVTIndustrialsMajor ChemicalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ingevity free cash flow
In the quarter ended Jun 30, 2026, Ingevity generated -$13.8 million of operating cash flow and spent $10.3 million on capital expenditures. That left free cash flow of -$24.1 million, a free-cash-flow margin of -7.7% of revenue. Free cash flow was down 136.1% from the prior year's $66.8 million.
Ingevity returned $34.5 million to shareholders through share repurchases.
Summary generated from market data by MetaCap's automated system. Methodology
Ingevity cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 35.30M | 59.80M | -84.60M | 43.50M | -146.50M | 20.50M | 16.60M | -107.20M | -283.70M | -56.00M | -116.80M | 25.20M |
| Net Income growth (YoY) | — | +191.71% | -609.64% | — | — | — | — | -525.40% | -899.15% | -210.45% | -848.72% | -66.58% |
| Depreciation & Amortization | 22.00M | 22.70M | 27.90M | 28.00M | 25.60M | 24.90M | 25.20M | 26.20M | 27.30M | 29.60M | 30.70M | 30.60M |
| Stock-Based Compensation | 4.20M | 4.80M | 4.50M | 5.30M | 4.40M | 4.10M | 2.10M | 3.10M | 2.40M | 4.30M | 2.30M | -600.00K |
| Change in Working Capital | -7.80M | -62.50M | 55.50M | 22.80M | -1.00M | -26.20M | 69.70M | 24.40M | -1.60M | -36.70M | 122.50M | 12.60M |
| Operating Cash Flow | -13.80M | -2.00M | 97.10M | 129.70M | 79.00M | 25.40M | 64.50M | 46.50M | 29.70M | -12.10M | 46.20M | 105.20M |
| Capital Expenditures | -10.30M | -10.30M | -23.60M | -11.90M | -12.20M | -10.00M | -24.90M | -18.00M | -18.10M | -16.60M | -29.20M | -33.50M |
| Investing Cash Flow | 75.40M | 106.30M | -15.10M | -28.10M | -2.80M | -11.50M | -28.00M | -17.40M | -17.80M | -16.30M | -24.70M | -32.30M |
| Share Repurchases | -34.50M | -52.30M | -31.10M | -25.20M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt Issued | 163.70M | 713.80M | 81.80M | 51.00M | 66.20M | 92.30M | 254.00M | 30.30M | 38.80M | 81.40M | 136.80M | 41.70M |
| Debt Repaid | -167.60M | -718.00M | — | -120.70M | -129.00M | -100.30M | 119.30M | -36.20M | -28.10M | -55.00M | 240.10M | -95.30M |
| Financing Cash Flow | -37.60M | -61.80M | -83.40M | -94.80M | -63.00M | -11.00M | -97.60M | -6.30M | 10.30M | 23.40M | -6.50M | -53.30M |
| Net Change in Cash | 25.60M | 42.70M | -1.80M | 7.30M | 16.20M | 4.30M | -66.90M | 28.20M | 20.20M | -6.80M | 17.70M | 17.30M |
| Free Cash Flow | -24.10M | -12.30M | 73.50M | 117.80M | 66.80M | 15.40M | 39.60M | 28.50M | 11.60M | -28.70M | 17.00M | 71.70M |
This table shows 12 quarterly periods of Ingevity's cash flow statement, from Q2 2026 back to Q3 2023, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow NGVT's reporting calendar. What is a cash flow statement?